Pfizer Takes on Genzyme With New Gaucher Drug

Arlene Weintraub Last night, just hours after New York drug giant Pfizer (NYSE: PFE) reported first-quarter profits that suffered from generic competition on its blockbuster cholesterol drug atorvas…
Read the full story: Xconomy Life Sciences